Low-density (LDL) and high-density (HDLj) lipoproteins dose-dependently activate phosphoinositide turnover and elevate cytosolic free Ca 2+ concentrations ([Ca 1+ ]|) in cultured vascular smooth muscle cells (VSMCs) from either human (microarterioles and aorta) or rat (aorta) sources. High-performance liquid chromatography analysis of cell extracts revealed comparable spectra of inositol phosphate isomers generated in response to either LDL, HDL,, or angiotensin II (Ang II 10 Epidemiologic studies also show that hypertension is a major risk factor for development of atherosclerosis. 4 Different hypotheses have been proposed to explain the association between the two diseases, with the common etiologic denominators being either disturbances in plasma lipoprotein concentrations and cellular cholesterol homeostasis, 5 intracellular calcium overload, 6 or altered responses to growth factors and vasoregulatory hormones.
Concerted Effects of
growth plays a fundamental role in atheroscle-A. A . rotic lesion formation and is a characteristic feature in arteries from hypertensive patients and animals. 10 Epidemiologic studies also show that hypertension is a major risk factor for development of atherosclerosis. 4 Different hypotheses have been proposed to explain the association between the two diseases, with the common etiologic denominators being either disturbances in plasma lipoprotein concentrations and cellular cholesterol homeostasis, 5 intracellular calcium overload, 6 or altered responses to growth factors and vasoregulatory hormones.
1 -3 These theories are not mutually exclusive, however, and linkage between the latter two is predictable because growth factors and vasoregulatory hormones are known to mobilize intracellular calcium. The relation between lipoprotein/cholesterol disturbances and the calcium-based or agonist growth factor-based theories is less conspicuous, but it " 10 In accordance with these physiological effects are data demonstrating LDL-induced activation of second-messenger systems coupled to contraction in VSMCs, namely stimulation of phosphoinositide turnover and elevation of free cytoplasmic calcium concentrations. 1012 We have also recently 13 reported that high-density lipoproteins (HDL3S) elicit similar signal transduction processes in VSMCs. Since smooth muscle cells in vivo are in permanent contact with lipoproteins 14 as well as with a diverse array of vasoregulatory and growth-regulatory compounds, an important consideration is whether lipoproteins and other hormones may influence cellular second-messenger systems in conjunction with one another. In this regard, interactions between variant agonists on a given cell system may, theoretically, produce extremely diverse effects that range from synergy of cellular responses and effects to the complete loss of cell response due to heterologous desensitization. Knowledge of the nature of concerted actions between lipo-proteins and other signaling hormones and peptides on second-messenger systems in vascular cells may help us understand the mechanisms of the regulation of vascular tone, cell growth, and cell morphology in normal and hyperlipidemic conditions.
Of the diverse array of growth factors and vasoconstrictor hormones potentially involved in vascular (patho)physiology and therefore of concern with respect to signaling interactions with lipoproteins, angiotensin (Ang) II holds greatest interest because it possesses the properties of both a pressor hormone and a trophic peptide. 12 -15 To address the issue of concerted action between different agonists, we investigated cellular signaling processes elicited in cultured VSMCs by each of LDL, HDL), and Ang II as well as combinations of Ang II and the lipoproteins. Our data suggest that the low concentrations of lipoproteins that are normally present within the vascular bed may be important cofactors in the regulation of vessel tone or smooth muscle cell morphology and growth by Ang II.
Methods

Materials
Tissue culture media and plastic ware were from GIBCO AG (Basel, Switzerland) except for fetal calf serum (FCS), which was from Fakola AG (Basel, Switzerland). Nonmitogenic plasma-derived serum (PDS) was prepared as previously described.
2 ' 16 Dowex-AG 1-X8 (formate form) was purchased from Bio-Rad (Zurich, Switzerland). Ammonium dihydrogen phosphate (high-performance liquid chromatography [HPLC] grade) was from Fluka AG (Buchs, Switzerland). Human Ang II was from Sigma Chemical Co (St Louis, Mo). Fura 2-AM was from Molecular Probes, Eugene, Oregon.
Cell Culture
The isolation, phenotypic characterization, and propagation of VSMCs from the aorta of spontaneously hypertensive rats were performed as described previously. 16 The isolation, phenotypic characterization, and propagation of human VSMCs from either microarterioles associated with omental tissue or from the lower thoracic aorta (both obtained postoperatively) were performed according to previously described procedures. 11 Immunohistochemical characterization of all VSMC isolates (positive for smooth muscle-specific a-actin and negative for factor VIII) was performed on primary cultures as described. 11 ' 16 A single VSMC isolate from each of the different tissues (specified in figure and table legends) was used for the experiments, and each isolate used was between passages 4 and 13. Unless otherwise specified, cultures of VSMCs were rendered quiescent by serum deprivation and maintenance in serum-free medium containing 0.1% (wt/vol) bovine serum albumin for 48 hours before examination of signaling responses to agonists. Cell numbers were routinely determined using a Coulter counter after trypsinization of cell layers as previously described.
1116
Isolation of Lipoproteins
LDL (d, 1.019 to 1.063 g/mL) and HDL, (d, 1.125 to 1.20 g/mL) were isolated from the plasma of healthy men by using sequential buoyant density centrifugation techniques with the use of potassium bromide solutions for density adjustments. 17 LDL and HDL3 were exhaustively dialyzed against 0.15 mol/L NaCl before Lowry determination of protein concentrations and sterilization by filtration through 0.45-/im Gelman filters. One millimole per liter EDTA and 1 /tmol/L butylated hydroxytoluene were present during the entire isolation and dialysis procedure. Gradient sodium dodecyl sulfate-polyacrylamide (5% to 19%) gel electrophoresis revealed that HDL3 preparations were free of apolipoprotein (apo) B-100 protein and albumin and that LDL preparations contained only apoB-100 protein and were free of protein fragments known to be generated during LDL oxidation. 18 Lipoproteins were stored in sterile plastic tubes at 4°C.
Measurements of Phosphoinositide Turnover
VSMCs were grown to confluence on 24-well dishes and maintained for 48 hours thereafter under serumfree culture conditions (medium containing 0.1% [wt/ vol] bovine serum albumin) and 1 iiCVmL myo- [2- 3 H]inositol as described previously.
11
' 16 After removal of the radiolabeled medium and washing of the cell layers, VSMCs were preincubated for 20 minutes at 37°C in serum-free culture medium containing 15 mmol/L LiCl. 1116 Thereafter, agonists were added and incubations were terminated by addition of trichloroacetic acid to a final concentration of 4.6%, and after 30 minutes of gentle shaking at room temperature the trichloroacetic acid concentration was reduced to 1% by addition of water. Inositol phosphates in lysates were resolved into mono-, bis-, and trisphosphates by anion-exchange chromatography on Dowex-AG 1-X8 columns using the procedure of sequential batch elution with increasing concentrations of ammonium formate/0.1 mol/L formic acid as described previously.
'
16 ' 18 For experiments in which different isomers of inositol phosphate were resolved by HPLC, VSMCs were prepared for experimentation as above, except that myo- [2] [3] H]inositol was present at 5 tiCi/mL during the 48-hour prelabeling period. In these experiments (performed in quadruplicate) reactions were stopped by the aspiration of medium and by the addition of 1 mL chloroform/methanol/ HCl/phytin hydrolysate (1:3:0.04:5 P, /Ag/mL). Phytin hydrolysate was prepared as described previously. 19 After lipid extraction and separation of organic and aqueous phases, 18 1 mL of the upper aqueous phase was transferred into Eppendorf tubes, and after the addition of 25 [iL of 50 mmol/L D-mannitol, the samples were vacuum dried in a SpeedVac centrifuge and stored at -20°C until HPLC analysis. A further 100-^L aliquot of the upper aqueous phase was chromatographed on conventional Dowex-AG 1-X8 anion-exchange columns as described above to control for variability between parallel samples. Those samples determined to deviate by more than 10% of the mean value of parallel aliquots were not used for HPLC analysis. Thereafter, for HPLC analysis, vacuum-dried parallel samples (with standard deviation less than 10%) were pooled by solubilization in a total volume of 200 fiL water. Pooled samples were spiked with 5 /iL of a solution containing 1 mmol/L each of cAMP, GMP, ADP, GDP, ATP, and GTP, and 100-^AL aliquots were injected onto the column. The HPLC analysis of inositol phosphates was performed according to a previously described method 20 21 VSMCs were loaded with a l-/wnol/L fura 2-AM solution for 15 minutes at 37°C. The cultures were washed with PSS to remove unincorporated fura 2-AM and incubated for an additional 5 minutes at 37°C to allow diffusion of nonhydrolyzed dye from the cell. The coverslip was mounted in a chamber and placed on the thermoregulated stage of a Nikon Diaphot inverted epifiuorescence microscope that was part of a PhoCal fluorescence photon counting analyzer (Joyce Loebl, Gateshead, UK). Cells were illuminated with alternating 340-run and 380-nm light from a rotating filter wheel (6.25 Hz). Emission from either single cells or the cell monolayer as a whole was monitored at 500 nm. Data were analyzed using the PhoCal software. Calibrations were performed by permeabilization of the cells with 5x10 mol/L digitonin to obtain F,,,,, followed by the addition of 10 mmol/L tris(hydroxymethyl)aminomethane-EGTA to obtain F^,,. [Ca 2+ ], was calculated as described previously.
-22
Statistical Analysis
Data were statistically analyzed using the paired Student's t test.
Results
The dose-dependent stimulation of IP production in human microarteriolar VSMCs by lipoproteins is presented in Fig 1. The effects of LDL ( Fig 1A) and HDL, (Fig IB) were saturable, and half-maximally effective concentrations (EQos) were similar for the two lipoproteins (-50 ^ig/mL). When lipoproteins at different concentrations were added to VSMCs in combination with a fixed, low dose (2 nmol/L) of Ang II, the effects on IP production were additive (ie, the total effect was equal to the sum of the effects produced by each agonist individually) or even synergistic (ie, the total effect was greater than the sum of the individual effects). In combination with Ang II the EC50 values for LDL and HDL3 («=40 to 50 ^g/mL) were not different from those obtained for each lipoprotein per se. The IP accumulation response (in either human microarteriolar or rat aortic VSMCs) to a fixed concentration (50 /ig/mL) of either LDL or HDL3 in combination with different concentrations of Ang II was also approximately equal to or slightly greater than a summation of the effects of the lipoproteins per se and the corresponding concentration of Ang II (Fig 2) . The dose dependency of VSMCs for Ang II was not markedly influenced by inclusion of LDL or HDLj, and EQo values for Ang II-stimulated IP accumulation in either the absence or presence of lipoproteins were =5 to 10 nmol/L (Fig 2) . Results obtained with respect to 1,4-IP 2 and 1,4,5-IP 3 accumulation responses to lipoproteins and Ang II in these series of experiments were qualitatively similar to those presented in Figs 1 and 2 (data not shown, but see Table 1 ).
Lipopolysaccharide from Escherichia coli (up to 100 ng/mL), a common contaminant of lipoprotein isolates, did not stimulate either phosphoinositide catabolism or an elevation of [Ca 2+ ], in quiescent VSMC cultures from the rat aorta, human aorta, or human microarterioles (data not shown). Lipid extracts from LDL and HDL, were also ineffective in eliciting signaling events in VSMCs, and the phosphoinositide and [Ca 2+ ], responses of cells to Ang II in combination with either lipopolysaccharide or lipoprotein lipid extracts were ]i remained unchanged (data not shown) after exposure of VSMCs to EDTA and/or butylated hydroxytoluene (up to 100 ^tmol/L and 100 nmol/L, respectively, these being the maximal possible final concentrations of antioxidants in experimental protocols). We have also previously demonstrated 13 that the [Ca 2+ ], responses of VSMCs to LDL and HDL3 are kinetically distinct from that of growth factor peptides. Taken together, these control observations permit the exclusion of the hypothesis that the signaling responses of VSMCs to LDL and HDL3 (alone or in combination with Ang II) are due to either any effect of the antioxidants (butylated hydroxytoluene and EDTA) present in lipoprotein preparations or contamination of lipoprotein preparations by endotoxin, peptide mitogens, and potentially biologically active lipids.
To determine the nature of inositol phosphate isomers generated by VSMCs, extracts of water-soluble pHJinositol phosphates from control and 5-minutestimulated cells were separated by HPLC on an anionexchange column. The data in Table 1 show that the spectra of inositol phosphate isomers generated by human aortic VSMCs in response to LDL, HDL,, or Ang II were similar. Agonist-stimulated increases in inositol phosphate isomers occurred predominantly in 4-IP,, 1,4-IP 2 , and 1,3,4,5-IP 4 (Table 1 ). There was also a pronounced increase (=200% to 300% above basal) in a second IP 3 isomer (retention time of 31 minutes; Table 1) Table 1 are compatible with our previous findings 13 in human microarteriolar VSMCs in which LDL, HDL3, and Ang II generated comparable spectra of inositol phosphates after either 30 seconds or 5 minutes of stimulation. The rapid metabolic conversion of inositol polyphosphates is supported by observations that 1,3,4,5-IP 4 ,1,4,5-IP 3 , and 1,4-IP 2 levels were lower after 5 minutes than 30 seconds, whereas accumulation of 4-IP, increased with time. 13 The chromatographic elution profiles obtained after treatment of VSMCs with combinations of lipoproteins (LDL or HDL,, each at 50 jig/mL) and Ang II (2 nmol/L) were qualitatively comparable to those obtained for single agonist-treated VSMCs (Table 1) , and no additional peaks of radioactivity could be detected. The previously observed (Figs 1 and 2 ) additivity/ synergism of Ang II and lipoprotein effects on inositol phosphate accumulation were clearly evident for 4-IP,, 1,4-IP 2 , and 1,3,4-IP 3 , which increased to =500% to 700% above basal compared with the =200% to 300% increases induced by singly applied agonists (Table 1) . Since the experimentally obtained increases in these isomers after exposure of VSMCs to Ang II plus LDL or Ang II plus HDL3 were =1.5-fold to twofold greater than the sum of increases provoked by each agonist alone, the effects of lipoproteins and Ang II may be described as synergistic.
Representative tracings of the effects of lipoproteins and Ang II on [Ca 2+ ], in fura 2-loaded human aortic •00. ], may also be described as synergistic (Fig 3A and 3B) . Absolute values for the maximal increases in [Ca 2+ ], (above baseline) induced by the different agonists are presented in Fig 3C. The experimentally obtained maximal increases in [Ca 2+ ]i in response to combinations of Ang II/LDL (=700 nmol/L) or Ang II/HDL, (=850 nmol/L) were significantly greater (P<.01) than the theoretical sum (=550 nmol/L) of the maximal increases produced by each agonist alone.
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To exclude the hypothesis that the additivity/synergism of the effects of lipoproteins and Ang II on Ca 2+ mobilization might be a function of heterogeneity of cellular populations (ie, containing different clones selectively responding to one or another of the agonists), HDLj, LDL, and Ang II were sequentially added to the cell chamber with simultaneous registration of fluorescence signals from a single cell. The representative tracing presented (Fig 4) demonstrates that the same cell can respond to all tested agonists. Such multiagonist responsiveness by a single VSMC was a consistent observation in cultures of VSMCs from human (aorta and microarterioles) and rat (aorta) sources, and we can conclude that VSMCs express the full complement of receptors/recognition sites for LDL, HDL3, and Ang II.
The sequential [Ca 2+ ], responsiveness of VSMCs to lipoproteins and Ang II (Fig 4) provided some evidence for a lack of heterologous desensitization by lipoproteins of the [Ca 2+ ]i response to Ang II. We further investigated this issue by examining the influence of H]inositol under serum-free culture conditions either without (control) or with LDL or HDL, (each at 100 jig/mL) during the 48-hour prelabeling period. Cells were then washed with and incubated for 30 minutes in medium containing 15 mmol/L LiQ before stimulation with LDL, HDL), or Ang II. Reactions were terminated after 5 minutes and the 3 H content in total inositol phosphates (mono-, bis-, and trisphosphates) was determined. 3 H content in total inositol phosphates is given as disintegrations per minute per well. All experimental details are described in "Methods." Values given are mean±SD from data obtained in four separate experiments. In a single experiment performed on rat VSMCs qualitatively similar results were obtained. Cell numbers in these experiments were «°2.3 to 2.5 xlO 3 cells per well. 'No significant difference in stimulation above basal between control and LDL-pretreated cultures. tNo significant difference in stimulation above basal between control and HDLj-pretreated cultures.
LDL on Ang II-stimulated phosphoinositide catabolism. The response of VSMCs to Ang II (2 nmol/L) was unchanged whether this peptide was added either simultaneously with LDL or after preincubation of human microarteriolar VSMCs with 100 jtg/mL LDL for up to 10 minutes (data not shown), thus suggesting that LDL produces no desensitization of the phosphoinositide turnover response to Ang II over this short-term period. To determine whether prolonged preincubation with lipoproteins might eventually result in desensitization of the response to Ang II as well as loss of responsiveness to lipoproteins, human microarteriolar VSMCs were cultured for 48 hours before experimentation in serum-free medium without (control) or with inclusion of either LDL or HDL3 (each at 100 /xg/mL). Cells were then washed and incubated in serum-free medium containing 15 mmol/L LiCl for 20 minutes before addition of agonists. The inositol phosphate accumulation responses to either lipoproteins (at 20 and 100 p,g/mL) or Ang II (1 ^rnol/L) in lipoproteinpretreated VSMCs were not significantly different from the corresponding responses in control VSMCs (Table  2) . However, as shown in Table 3 , the ability of LDL, HDL3, or Ang II to stimulate phosphoinositide catabolism in VSMCs from both rat and human sources was sensitive to the presence of growth factors. The inclusion of FCS during the 48-hour prelabeling culture period resulted in a complete blockade of the effects of LDL and HDL, and =60% inhibition of the effects of Ang II. In contrast, under the same conditions PDS, which is essentially mitogen free, 2 did not significantly influence VSMC responsiveness to either lipoproteins or Ang II (Table 3) .
Discussion
Some studies have demonstrated endothelium-dependent vasoregulatory effects of lipoproteins, which probably result from the impairment of effects of endothelium-derived relaxing factor synthesized by endothelial cells. The present study demonstrated that when VSMCs are exposed to combinations of Ang II and either LDL or HDL3, an additive or even synergistic activation of these second-messenger systems occurs. The concerted actions of lipoproteins and the vasoconstrictor peptide on intracellular signaling was true for cell isolates from different species (human and rat) and from different vessels (aorta and microarterioles). Lipoproteins and Ang II exert similar actions on VSMCs with respect to the generation of second messengers in VSMCs (this study and Reference 13). The present study also demonstrated that the effects of LDL and HDL3 on phosphoinositide catabolism are dose dependent and saturable, indicating the involvement of saturable recognition sites in the manner characteristic of hormone action. HPLC analysis of water-soluble extracts from human aortic VSMCs (Table 1) or human microarteriolar VSMCs 13 revealed that lipoproteins stimulate production of the same isomers of inositol phosphates (4-IP,, 1,4-IP 2 , 1,3,4-IP 3 , 1,4,5-IP 3 , and 1,3,4,5-IP4) as those formed in response to Ang II. This spectrum of newly generated inositol phosphates presupposes that they originate from the phospholipase C-catalyzed cleavage of phosphatidylinositol 4-monophosphate and/or phosphatidylinositol 4,5-bisphosphate. 23 - 24 Moreover, both LDL and HDL, induced a rapid, transient increase of [Ca 2+ ], in VSMCs that is analogous to the concomitant intracellular Ca ^-mobilizing action of vasoconstrictor hormones (eg, Ang II) that stimulate phospholipase C-mediated polyphosphoinositide breakdown. 28 Our data thus permit the assumption that lipoproteins stimulate potyphosphoinositide-specific phospholipase C, a recognized key enzyme in the activation of cells by many hormones. 23 - 24 The molecular mechanism whereby lipoproteins stimulate cell signaling is not clear. Our preliminary investigations in this direction have shown that apoprotein (total) extracts from LDL or HDL3 effectively stimulate both phosphoinositide catabolism and intracellular Ca 2+ mobilization in VSMC cultures. We are currently investigating which specific apoprotein component(s) mediate the signaling effects of LDL and HDL3 and to identify specific receptor(s) used by the lipoproteins for signal transduction.
The similarity between lipoproteins and Ang II with respect to cellular signaling in VSMCs (this study and References 10 to 13 and 27) raises the likelihood of an interaction between the two types of agonists at the level of generation of second messengers. We found an apparent synergism of action between Ang II and either LDL or HDL3 with respect to both phosphoinositide catabolism and elevation of [Ca 2+ ]i in VSMCs. When the data from combination experiments with a fixed lipoprotein dose and varying concentrations of Ang II (Fig 2) are examined in terms of increase in activation, the effect of concerted actions on cell responses would appear to be most prominent (and therefore may be of most physiological significance) at lower concentrations of Ang II (10"' to 10~8 mol/L). At these concentrations the increase (above basal) in inositol phosphate accumulation was =1.2-to 1.8-fold for Ang II alone and •=>2.0-to 2.7-fold in combination with lipoproteins (vs =1.5-fold for lipoproteins alone). This represents an approximate doubling of the increase in activation by the individual agonists. The more convincing evidence for synergistic effects between lipoproteins and Ang II on VSMC signaling systems is that experimental increases of [Ca 2+ ]| and several inositol phosphate isomers produced after simultaneous addition of lipoproteins and Ang II were significantly greater than the theoretical sum of increases produced by the individual agonists. Although synergistic effects on 1,4,5-IP 3 generation were not observed under the given experimental conditions (5 minutes of stimulation), those inositol phosphate isomers in which there was a clear synergistic effect (4-IP,, 1,4-IP 2 , and 1,3,4,5-IP«) are recognized metabolic conversion products of 1,4,5-IP3. 23 - 24 Resting concentrations of vasoactive hormones are usually low, and their biological efficacy only becomes manifest after concentrations rapidly increase in response to an appropriate stimulus. In contrast, lipoproteins are in permanent contact with VSMCs in vivo and at concentrations 14 -29 close to those inducing saturating effects on signal transduction systems (this study and References 10 to 12 and 27). Thus, although blood lipoproteins clearly possess "hormone-like" signaling properties, their biological mechanisms of action in vivo are expected to be unusual and different from most vasoconstrictors. It is well known that short or prolonged hormonal stimulation may result in homologous and/or heterologous desensitization of receptors and second-messenger systems. 30 This phenomenon has been demonstrated in cultured VSMCs for Ang II and vasopressin, 31 and it was thus of interest to determine whether pretreatment of VSMCs with lipoproteins could modify cellular sensitivity to themselves and Ang II. We found that neither short-term nor long-term preincubation of VSMCs with lipoproteins influenced the subsequent signaling responses of the cells to Ang II, LDL, or HDL3. Full agonist responsiveness was also retained by VSMCs exposed for 48 hours to 5% PDS (which contains normal serum levels of lipoproteins but is deficient in serum mitogens/growth factors). Thus, lipoproteins do not induce either homologous or heterologous desensitization of second-messenger systems. In contrast, after preincubation with 5% FCS the sensitivity of VSMCs to lipoproteins was completely lost and that to Ang II was significantly reduced, suggesting that growth factors/mitogens are effective modulators of cellular responsiveness to both hormones and lipoproteins.
In conclusion, we propose that since in vivo concentrations of LDL and HDL within the vessel intima/ media are comparable to those eliciting cellular responses in vitro, then the phospholipase C and Ca 2+ -mobilizing systems of VSMCs in vivo may be subject to permanent regulatory control by lipoproteins. Ca 2+ -dependent and protein kinase C-mediated phosphorylation of a number of VSMC proteins can modulate the shape, growth, and contractility of these cells. also known to be Ca 2+ regulated. 12 - 15 Thus, disturbances of the proposed signaling functions of lipoproteins, together with their potentiation of the effects of powerful vasoactive compounds such as Ang II, may underlie the known association of hypertension with dyslipoproteinemia 33 and the abnormal reactivity of atherosclerotic vessels. 34 
